I'm thinking it could have been the safety prelim
Post# of 148288
(Total Views: 469)
Posted On: 08/23/2020 3:12:48 PM
I'm thinking it could have been the safety prelim released also, it was before 3 weeks ago. Safety is a huge issue, and almost exclusive to Leronlimab.
As little as I know (not a doctor), plasma should not be a "world wide" option...slow to provide, may or may not work. They don't even know for sure how many are resistant once they get Covid, or how long they would stay resistant.
I just can't believe it would be Remdesivir. Just can't. Please.
The inhaler seems way too new and thus far unproven (?).
Back to safety. Plus now the CD10 results, IT WORKS, the FDA quick look at CD12, the OWS "discussions," and we all want it!!
To The Moon Alice
As little as I know (not a doctor), plasma should not be a "world wide" option...slow to provide, may or may not work. They don't even know for sure how many are resistant once they get Covid, or how long they would stay resistant.
I just can't believe it would be Remdesivir. Just can't. Please.
The inhaler seems way too new and thus far unproven (?).
Back to safety. Plus now the CD10 results, IT WORKS, the FDA quick look at CD12, the OWS "discussions," and we all want it!!
To The Moon Alice
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼